应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01099 国药控股
未开盘 09-03 16:08:55
18.460
-0.040
-0.22%
最高
18.690
最低
18.330
成交量
734.41万
今开
18.590
昨收
18.500
日振幅
1.95%
总市值
576.07亿
流通市值
247.70亿
总股本
31.21亿
成交额
1.35亿
换手率
0.55%
流通股本
13.42亿
市净率
0.66
ROE
7.83%
每股收益
2.47
52周最高
22.740
52周最低
15.403
市盈率
7.48
股息
0.74
股息收益率
0.04
ROA
2.54%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
国药控股宁夏医疗科技发展有限公司中标平罗县妇幼保健计划生育服务中心生物刺激反馈系统采购项目
DoNews · 09-03 15:56
国药控股宁夏医疗科技发展有限公司中标平罗县妇幼保健计划生育服务中心生物刺激反馈系统采购项目
每日卖空追踪 | 国药控股 09月03日卖空量成交63.44万股,卖空比例为9.35%
市场透视 · 09-03 08:30
每日卖空追踪 | 国药控股 09月03日卖空量成交63.44万股,卖空比例为9.35%
国药控股09月03日主力净流出139.6万元 散户资金买入
市场透视 · 09-03 08:15
国药控股09月03日主力净流出139.6万元 散户资金买入
国药控股海南鸿益等公司中标医疗设备采购项目
DoNews · 09-03 05:53
国药控股海南鸿益等公司中标医疗设备采购项目
国药控股贵州医疗器械有限公司等4家企业入围贵州省人民医院医用耗材及试剂采购项目
DoNews · 09-02 05:48
国药控股贵州医疗器械有限公司等4家企业入围贵州省人民医院医用耗材及试剂采购项目
国药控股又一家公司因串标被处罚复议被驳回,国药控股业绩下滑
中金在线 · 09-01 13:58
国药控股又一家公司因串标被处罚复议被驳回,国药控股业绩下滑
每日卖空追踪 | 国药控股 09月01日卖空量成交44.36万股,卖空比例为5.65%
市场透视 · 09-01 08:30
每日卖空追踪 | 国药控股 09月01日卖空量成交44.36万股,卖空比例为5.65%
四大药商最新业绩比拼,国控、上药、华润、九州通(附图表)
动脉网 · 08-30
四大药商最新业绩比拼,国控、上药、华润、九州通(附图表)
中金:维持国药控股(01099)跑赢行业评级 目标价24.7港元
智通财经 · 08-27
中金:维持国药控股(01099)跑赢行业评级 目标价24.7港元
大行评级|美银:微升国药控股目标价至23港元 重申“买入”评级
格隆汇 · 08-26
大行评级|美银:微升国药控股目标价至23港元 重申“买入”评级
每日卖空追踪 | 国药控股 08月26日卖空量成交49.04万股,卖空比例为8.76%
市场透视 · 08-26
每日卖空追踪 | 国药控股 08月26日卖空量成交49.04万股,卖空比例为8.76%
大行评级|花旗:国药控股管理层预期下半年起或出现转折点 目标价微降至22.7港元
格隆汇 · 08-26
大行评级|花旗:国药控股管理层预期下半年起或出现转折点 目标价微降至22.7港元
美银证券:升国药控股目标价至23港元 重申“买入”评级
新浪港股 · 08-26
美银证券:升国药控股目标价至23港元 重申“买入”评级
美银证券:升国药控股(01099.HK)目标价至23港元 重申“买入”评级
智通财经 · 08-26
美银证券:升国药控股(01099.HK)目标价至23港元 重申“买入”评级
脑机接口再迎突破;国药控股上半年营业利润74.5亿元
21世纪经济报道 · 08-26
脑机接口再迎突破;国药控股上半年营业利润74.5亿元
国药控股(01099)中期归母净利同比减少6.43% 不派息
金吾财讯 · 08-25
国药控股(01099)中期归母净利同比减少6.43% 不派息
国药控股(01099.HK)发布中期业绩,归母净利润34.66亿元 同比减少6.43%
智通财经 · 08-24
国药控股(01099.HK)发布中期业绩,归母净利润34.66亿元 同比减少6.43%
国药控股:上半年营业利润74.5亿元
金融界 · 08-24
国药控股:上半年营业利润74.5亿元
国药控股在港交所公告称上半年营收2860亿元人民币(下同)上半年营业利润74.5亿元上半年净利润34.7亿元上半年毛利率
智通财经 · 08-24
国药控股在港交所公告称上半年营收2860亿元人民币(下同)上半年营业利润74.5亿元上半年净利润34.7亿元上半年毛利率
国药控股:上半年净利润2.95亿元 同比增加1.02%
格隆汇 · 08-21
国药控股:上半年净利润2.95亿元 同比增加1.02%
加载更多
公司概况
公司名称:
国药控股
所属市场:
SEHK
上市日期:
2009-09-23
主营业务:
国药控股股份有限公司是一家主要从事药品、医疗保健产品及医疗器械批发和零售业务的中国公司。该公司通过四个部门运营业务。医药分销部门为国内外药品及保健品制造商及其他供货商提供分销、物流及其他加值服务。器械分销部门向客户分销医疗器材。医药零售业务部门拥有直接经营或特许经营的零售药局网路。其他业务部门从事药品、化学试剂及实验室用品的制造与销售。
发行价格:
--
{"stockData":{"symbol":"01099","market":"HK","secType":"STK","nameCN":"国药控股","latestPrice":18.46,"timestamp":1756886935003,"preClose":18.5,"halted":0,"volume":7344127,"delay":0,"floatShares":1341810740,"shares":3120656191,"eps":2.468452057845309,"marketStatus":"未开盘","change":-0.04,"latestTime":"09-03 16:08:55","open":18.59,"high":18.69,"low":18.33,"amount":135358567,"amplitude":0.019459,"askPrice":18.47,"askSize":12800,"bidPrice":18.46,"bidSize":8800,"shortable":3,"etf":0,"ttmEps":2.391569432272004,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756949400000},"marketStatusCode":0,"adr":0,"listingDate":1253635200000,"exchange":"SEHK","adjPreClose":18.5,"dividendRate":0.040196,"openAndCloseTimeList":[[1756863000000,1756872000000],[1756875600000,1756886400000]],"volumeRatio":1.0696931175619786,"lotSize":400,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SNP.HK","impliedVol":0.2953,"impliedVolPercentile":0.2317},"requestUrl":"/m/hq/s/01099","defaultTab":"news","newsList":[{"id":"2564536348","title":"国药控股宁夏医疗科技发展有限公司中标平罗县妇幼保健计划生育服务中心生物刺激反馈系统采购项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2564536348","media":"DoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564536348?lang=zh_cn&edition=full","pubTime":"2025-09-03 23:56","pubTimestamp":1756914963,"startTime":"0","endTime":"0","summary":"天眼查App显示,2025年9月2日,平罗县妇幼保健计划生育服务中心发布了生物刺激反馈系统采购项目的中标结果公告。中标供应商为国药控股宁夏医疗科技发展有限公司,中标金额为295000.00元。采购地点为宁夏回族自治区。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903235702977595a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903235702977595a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","LU1115378108.SGD","LU0640798160.USD","BK1500","01099","BK1197"],"gpt_icon":0},{"id":"2564485853","title":"每日卖空追踪 | 国药控股 09月03日卖空量成交63.44万股,卖空比例为9.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564485853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564485853?lang=zh_cn&edition=full","pubTime":"2025-09-03 16:30","pubTimestamp":1756888219,"startTime":"0","endTime":"0","summary":"国药控股北京时间09月03日,跌0.22%,卖空量成交63.44万股%,较上一交易日减少44.66%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903172002a70d4d0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903172002a70d4d0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1115378108.SGD","BK1515","BK1500","01099","BK1197","LU0640798160.USD"],"gpt_icon":0},{"id":"2564485543","title":"国药控股09月03日主力净流出139.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2564485543","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564485543?lang=zh_cn&edition=full","pubTime":"2025-09-03 16:15","pubTimestamp":1756887341,"startTime":"0","endTime":"0","summary":"09月03日, 国药控股股价跌0.22%,报收18.46元,成交金额1.4亿元,换手率0.55%,振幅1.95%,量比1.07。国药控股今日主力资金净流出139.6万元,上一交易日主力净流入48.1万元。该股近5个交易日下跌2.49%,主力资金累计净流入2522.3万元;近20日主力资金累计净流入1.8亿元,其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903170157a4b1776e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903170157a4b1776e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1500","01099","LU1115378108.SGD","LU0640798160.USD","BK1197","BK1515"],"gpt_icon":0},{"id":"2564934837","title":"国药控股海南鸿益等公司中标医疗设备采购项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2564934837","media":"DoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564934837?lang=zh_cn&edition=full","pubTime":"2025-09-03 13:53","pubTimestamp":1756878783,"startTime":"0","endTime":"0","summary":"天眼查App显示,2025年9月2日,海南省三亚市某单位公示了2025年第二批医疗设备采购项目采购结果。采购包(6)由国药控股海南鸿益有限公司以250000.00元中标,采购包(7)由广东大琦医疗器械有限公司以510000.00元中标,采购包(9)由广东升捷仪器有限公司以425150.00元中标。公示期限为2025年9月2日至2025年9月4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090313541095103529&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090313541095103529&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1115378108.SGD","BK1515","BK1500","01099","BK1197","LU0640798160.USD"],"gpt_icon":0},{"id":"2564388447","title":"国药控股贵州医疗器械有限公司等4家企业入围贵州省人民医院医用耗材及试剂采购项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2564388447","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564388447?lang=zh_cn&edition=full","pubTime":"2025-09-02 13:48","pubTimestamp":1756792083,"startTime":"0","endTime":"0","summary":"天眼查App显示,2025年9月1日,贵州省人民医院发布部分医用耗材、体外诊断试剂采购项目(GZWH-155)(二次)候选排名公示。本次采购项目为医用耗材及体外诊断试剂,采购方式为比选,采购人系贵州省人民医院。经评审,国药控股贵州医疗器械有限公司、贵州鑫源医疗设备有限公司、贵州省亚中冷链医药物流有限责任公司、贵州信达利生物科技有限公司4家企业入围。此次公告类型为中标结果,公示期限为2025年9月1日至2025年9月3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090213490697722a93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090213490697722a93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1222","BK1500","09997","BK1583","LU0640798160.USD","LU1115378108.SGD","BK1515","01099","09996","BK1100","BK1574","BK1197"],"gpt_icon":0},{"id":"2564829828","title":"国药控股又一家公司因串标被处罚复议被驳回,国药控股业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2564829828","media":"中金在线","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564829828?lang=zh_cn&edition=full","pubTime":"2025-09-01 21:58","pubTimestamp":1756735082,"startTime":"0","endTime":"0","summary":"公告显示,经依法调查,国药控股河南医疗器械有限公司所提复议事项不成立,依据军队采购有关规定,复议申请被驳回,原违规处理决定维持。股权关系方面,据企业信息查询平台爱企查数据,国药控股河南器械为国药控股河南股份有限公司的全资子公司,而国药控股河南股份有限公司由国药控股股份有限公司持股 80%并实际控制。据8月25日,国药控股股份有限公司作为港交所上市公司发布的《二零二五年中期业绩公告》,其主要业绩指标下滑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901221109a7099f80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901221109a7099f80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","LU1115378108.SGD","01099","BK1515","BK1500","LU0640798160.USD"],"gpt_icon":0},{"id":"2564298978","title":"每日卖空追踪 | 国药控股 09月01日卖空量成交44.36万股,卖空比例为5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564298978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564298978?lang=zh_cn&edition=full","pubTime":"2025-09-01 16:30","pubTimestamp":1756715418,"startTime":"0","endTime":"0","summary":"国药控股北京时间09月01日,涨0.43%,卖空量成交44.36万股%,较上一交易日减少66.74%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901173110a4ad1e87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901173110a4ad1e87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1115378108.SGD","BK1197","01099","LU0640798160.USD","BK1500","BK1515"],"gpt_icon":0},{"id":"2563832042","title":"四大药商最新业绩比拼,国控、上药、华润、九州通(附图表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2563832042","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563832042?lang=zh_cn&edition=full","pubTime":"2025-08-30 18:57","pubTimestamp":1756551420,"startTime":"0","endTime":"0","summary":"2025年上半年,国药控股、上海医药、华润医药和九州通四家国内头部药商发布了半年度业绩报告。国药控股以2860.43亿元的营收继续领跑,但其营收同比下降2.95%;上海医药与华润医药分别实现1.56%和0.50%的同比增长,而九州通则以5.10%的增速排名第一。在归母净利润方面,上海医药以44.59亿元居首,同比增长51.56%,但剔除一次性因素后净利润为27.82亿元,同比下降2.06%;九州通实现19.70%的增长,主要得益于新兴业务板块的快速增长。医药分销业务方面,国药控股出现下滑,其余三家企业均实现增长。整体来看,四家企业的营收和净利润表现分化明显,长期盈利趋势也存在较大差异。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250831011211950829fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250831011211950829fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1115378108.SGD","BK1197","01099","LU0640798160.USD","BK1500","BK1515"],"gpt_icon":0},{"id":"2562624147","title":"中金:维持国药控股(01099)跑赢行业评级 目标价24.7港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562624147","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562624147?lang=zh_cn&edition=full","pubTime":"2025-08-27 09:15","pubTimestamp":1756257302,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中金发布研报称,维持国药控股2025年/2026年净利润预测74.75亿元人民币/79.26亿元人民币,分别同比增长6.0%/6.0%。该行维持跑赢行业评级和目标价24.7港币,对应2025年/2026年9.4倍/8.8倍市盈率,对应上涨空间27.2%。截至2025年6月底,国大药房门店数量8,591家,较2024年底净减少978家,1H25亏损店铺数量及占比较去年同期明显下降。1H25,国大药房净利润同比增长215.81%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1335957.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01099"],"gpt_icon":0},{"id":"2562896107","title":"大行评级|美银:微升国药控股目标价至23港元 重申“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2562896107","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562896107?lang=zh_cn&edition=full","pubTime":"2025-08-26 17:07","pubTimestamp":1756199246,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159883","BK1515","01099","BK1100","LU0640798160.USD","BK1574","161027","BK1500","BK1583","BK1222","09997","BK1197","LU1115378108.SGD","09996"],"gpt_icon":0},{"id":"2562737147","title":"每日卖空追踪 | 国药控股 08月26日卖空量成交49.04万股,卖空比例为8.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562737147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562737147?lang=zh_cn&edition=full","pubTime":"2025-08-26 16:30","pubTimestamp":1756197019,"startTime":"0","endTime":"0","summary":"国药控股北京时间08月26日,跌2.46%,卖空量成交49.04万股%,较上一交易日减少81.59%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。港股数据实时性强,适合短线跟踪;美股因T+2延迟,更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250826172558a49fc06f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250826172558a49fc06f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1500","BK1197","BK1515","01099","LU1115378108.SGD","LU0640798160.USD"],"gpt_icon":0},{"id":"2562820069","title":"大行评级|花旗:国药控股管理层预期下半年起或出现转折点 目标价微降至22.7港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562820069","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562820069?lang=zh_cn&edition=full","pubTime":"2025-08-26 15:00","pubTimestamp":1756191642,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1100","LU0106831901.USD","BK1583","BK4534","LU1244550221.USD","LU0130102774.USD","LU1366192091.USD","LU0130517989.USD","LU0310800965.SGD","LU2456880835.USD","LU2125154778.USD","LU0162691827.USD","BK4559","LU0640798160.USD","LU1244550577.SGD","01099","LU2236285917.USD","IE00BSNM7G36.USD","LU0098860793.USD","BK1500","LU1201861249.SGD","BK1197","LU0648001328.SGD","BK1515","LU2125154935.USD","LU1267930227.SGD","LU0320765646.SGD","BK1574","BK4585","LU1668664300.SGD","LU0072461881.USD","LU0170899867.USD","LU1115378108.SGD","09997","159883","BK4566","LU0477156953.USD","LU2360032135.SGD","LU2462157665.USD","BK4504","LU2417539215.USD","BK1222","BK4207","LU0052756011.USD","LU1244550494.USD","LU0128525689.USD","LU1162221912.USD","09996","LU0980610538.SGD","LU1791807156.HKD"],"gpt_icon":0},{"id":"2562200328","title":"美银证券:升国药控股目标价至23港元 重申“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2562200328","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562200328?lang=zh_cn&edition=full","pubTime":"2025-08-26 14:59","pubTimestamp":1756191540,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 麦格理发布研报称,招金矿业(01818)受惠于金价强势,核心盈利达约14亿元人民币。该行预期公司将于2026及27年实现2至3吨产能提升。该行看好公司的低成本优势及产量增长潜力,维持“跑赢大市”评级,目标价由25港元升至26港元,并分别升2025至27年各年每股盈测分别5%、0.8%及0.8%。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:史丽君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2025-08-26/doc-infnhvhf8320028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01099","161027"],"gpt_icon":0},{"id":"2562020767","title":"美银证券:升国药控股(01099.HK)目标价至23港元 重申“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2562020767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562020767?lang=zh_cn&edition=full","pubTime":"2025-08-26 14:12","pubTimestamp":1756188778,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","CNHmain","09997","CYB","01099","BK1100","MCNHmain","BK1500","LU0640798160.USD","UCmain","MUCmain","BK1222","LU1115378108.SGD","BK1574","BK1197","161027","BK1515","159883","09996"],"gpt_icon":0},{"id":"2562333272","title":"脑机接口再迎突破;国药控股上半年营业利润74.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562333272","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562333272?lang=zh_cn&edition=full","pubTime":"2025-08-26 08:40","pubTimestamp":1756168850,"startTime":"0","endTime":"0","summary":"政策动向国家药监局器审中心发布多项注册审查指导原则近日,国家药监局器审中心组织修订了《癌症筛查体外诊断试剂临床评价注册审查指导原则》、《结直肠癌筛查体外诊断试剂临床评价注册审查指导原则》、《高危型人乳头瘤病毒(HPV)核酸检测及基因分型试剂注册审查指导原则(2025年修订稿)》、《人类嗜T淋巴细胞病毒抗体检测试剂注册审查指导原则》,以进一步规范癌症筛查体外诊断试剂等产品的管理。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202508263494233442.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202508263494233442.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1500","LU1115378108.SGD","BK1515","LU0640798160.USD","01099","BK1197"],"gpt_icon":0},{"id":"2562293848","title":"国药控股(01099)中期归母净利同比减少6.43% 不派息","url":"https://stock-news.laohu8.com/highlight/detail?id=2562293848","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562293848?lang=zh_cn&edition=full","pubTime":"2025-08-25 08:18","pubTimestamp":1756081090,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国药控股 公告,截至2025年6月30日止六个月,归属母公司持有者期内溢利为34.66亿元,同比减少6.43%,每股基本盈利1.11元,去年同期为1.19元。期内,集团器械分销收入为570.53亿元,同比下降2.46%,占集团总收入比例为19.22%,其下降主要是由于带量采购政策实施的影响,毛利率较高的器械品类销售收入有所下降,以及受终端需求结构变化影响的医用耗材收入稳定增长。毛利率为7.11%,同比减少0.34个百分点。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/NmY0NGUwYzEyZTE3Njc2MTkyNTUxNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NmY0NGUwYzEyZTE3Njc2MTkyNTUxNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1964681","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1115378108.SGD","BK1500","LU0640798160.USD","01099","BK1515","BK1197"],"gpt_icon":0},{"id":"2562267204","title":"国药控股(01099.HK)发布中期业绩,归母净利润34.66亿元 同比减少6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562267204","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562267204?lang=zh_cn&edition=full","pubTime":"2025-08-25 06:51","pubTimestamp":1756075902,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01099","MUCmain","BK1515","LU0640798160.USD","BK1197","CNHmain","BK1500","MCNHmain","CYB","UCmain","LU1115378108.SGD"],"gpt_icon":0},{"id":"2562626750","title":"国药控股:上半年营业利润74.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562626750","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562626750?lang=zh_cn&edition=full","pubTime":"2025-08-25 06:09","pubTimestamp":1756073376,"startTime":"0","endTime":"0","summary":"国药控股在港交所公告称,上半年营收2860亿元人民币(下同),上半年营业利润74.5亿元,上半年净利润34.7亿元,上半年毛利率7.11%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/25060952656257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1500","LU0640798160.USD","LU1115378108.SGD","BK1515","01099","BK1197"],"gpt_icon":0},{"id":"2562678562","title":"国药控股在港交所公告称上半年营收2860亿元人民币(下同)上半年营业利润74.5亿元上半年净利润34.7亿元上半年毛利率","url":"https://stock-news.laohu8.com/highlight/detail?id=2562678562","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562678562?lang=zh_cn&edition=full","pubTime":"2025-08-25 06:09","pubTimestamp":1756073373,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1500","LU1115378108.SGD","CYB","CNHmain","UCmain","BK1197","BK1515","HEXmain","MUCmain","LU0640798160.USD","MCNHmain","01099"],"gpt_icon":0},{"id":"2561676194","title":"国药控股:上半年净利润2.95亿元 同比增加1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561676194","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561676194?lang=zh_cn&edition=full","pubTime":"2025-08-21 19:55","pubTimestamp":1755777332,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["01099","HEXmain","BK1515","LU1115378108.SGD","BK1197","BK1500","LU0640798160.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinopharmgroup.com.cn","stockEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0128},{"period":"3month","weight":0.0267},{"period":"6month","weight":-0.0194},{"period":"1year","weight":0.0908},{"period":"ytd","weight":-0.0986}],"compareEarnings":[{"period":"1week","weight":0.0056},{"period":"1month","weight":0.0247},{"period":"3month","weight":0.0601},{"period":"6month","weight":0.0459},{"period":"1year","weight":0.4358},{"period":"ytd","weight":0.2634}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"国药控股股份有限公司是一家主要从事药品、医疗保健产品及医疗器械批发和零售业务的中国公司。该公司通过四个部门运营业务。医药分销部门为国内外药品及保健品制造商及其他供货商提供分销、物流及其他加值服务。器械分销部门向客户分销医疗器材。医药零售业务部门拥有直接经营或特许经营的零售药局网路。其他业务部门从事药品、化学试剂及实验室用品的制造与销售。","yearOnYearQuotes":[{"month":1,"riseRate":0.5625,"avgChangeRate":0.000304},{"month":2,"riseRate":0.5625,"avgChangeRate":0.030473},{"month":3,"riseRate":0.5,"avgChangeRate":0.010225},{"month":4,"riseRate":0.4375,"avgChangeRate":0.022869},{"month":5,"riseRate":0.625,"avgChangeRate":-0.004548},{"month":6,"riseRate":0.4375,"avgChangeRate":-0.005852},{"month":7,"riseRate":0.5,"avgChangeRate":-0.015111},{"month":8,"riseRate":0.4375,"avgChangeRate":0.012101},{"month":9,"riseRate":0.4375,"avgChangeRate":-0.010775},{"month":10,"riseRate":0.625,"avgChangeRate":0.041428},{"month":11,"riseRate":0.4375,"avgChangeRate":-0.009905},{"month":12,"riseRate":0.5625,"avgChangeRate":-0.002508}],"exchange":"SEHK","name":"国药控股","nameEN":"SINOPHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药控股(01099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药控股,01099,国药控股股票,国药控股股票老虎,国药控股股票老虎国际,国药控股行情,国药控股股票行情,国药控股股价,国药控股股市,国药控股股票价格,国药控股股票交易,国药控股股票购买,国药控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药控股(01099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}